211 related articles for article (PubMed ID: 26429219)
1. Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol.
Honeyball F; Murali-Ganesh R; Hruby G; Grimison P
Intern Med J; 2015 Oct; 45(10):1081-4. PubMed ID: 26429219
[TBL] [Abstract][Full Text] [Related]
2. Management of patients with non-seminomatous germ cell tumours stage I.
Rørth M; Cullen MH; Horwich A; Roth BJ
Prog Clin Biol Res; 1990; 357():295-303. PubMed ID: 2170995
[No Abstract] [Full Text] [Related]
3. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
Raghavan D; Boyer M
Prog Clin Biol Res; 1990; 350():309-18. PubMed ID: 2166960
[No Abstract] [Full Text] [Related]
4. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
5. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
6. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
von Eschenbach AC; Swanson DA; Johnson DE; Wishnow KI; Stephenson RA; Babaian RJ
Prog Clin Biol Res; 1991; 370():385-92. PubMed ID: 1718009
[No Abstract] [Full Text] [Related]
7. Compliance with follow-up for patients with stage 1 testicular germ cell tumour.
Cheung KT; Dat A; Wong P; Dowling C; Davis ID; Sengupta S
ANZ J Surg; 2021 Jan; 91(1-2):184-186. PubMed ID: 32618092
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
9. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
10. Surveillance in patients with stage I testicular nonseminomatous germ cell tumors.
Gez E; Wygoda M; Nussbaum N; Figer A; Gil RI; Inbal M
Cancer Invest; 1993; 11(1):10-4. PubMed ID: 8380748
[TBL] [Abstract][Full Text] [Related]
11. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
12. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
13. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
14. A third option in the management of patients with clinical stage I nonseminomatous germ cell tumor?
Gressler VH; Levine LA; Vogelzang NJ
J Clin Oncol; 1990 Jan; 8(1):4-8. PubMed ID: 2153195
[No Abstract] [Full Text] [Related]
15. [Therapy of germ cell tumors. Model for interdisciplinary treatment approach].
Schmoll HJ
Med Klin (Munich); 1996 Apr; 91 Suppl 3():80-4. PubMed ID: 8692125
[No Abstract] [Full Text] [Related]
16. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
17. The results of the treatment of stage I and II nonseminomatous germinal testicular tumors.
Akdaş A; Ilker Y; Kirkali Z; Bakkaloğlu M
Turk J Pediatr; 1984; 26(1-4):291-6. PubMed ID: 6100345
[No Abstract] [Full Text] [Related]
18. [Chemo-radiotherapeutic treatment of non-seminoma germ cell tumors of the testis in the advanced stage].
Krengli M; Pastore G; Invernizzi A; Maffei S
Minerva Med; 1987 Feb; 78(4):209-13. PubMed ID: 3031548
[TBL] [Abstract][Full Text] [Related]
19. [Non-surgical treatment of testicular cancer: guidelines for the urologist].
Páez Borda A; Llorente Abarca C; Herrero Payo A; Acebal Lucia J; Berenguer Sánchez A
Actas Urol Esp; 1993 Apr; 17(4):226-33. PubMed ID: 8393610
[TBL] [Abstract][Full Text] [Related]
20. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
